9 results
NSAIDs and GI versus CV risk

Follow www.instagram.com/rxnotes for more!

#pharmacology #comparison #cardiology #gi #nsaids #pain #medications #management
NSAIDs and GI versus ... #pharmacology #comparison ... #cardiology #gi ... #nsaids #pain #medications ... #management #riskfactors
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2017 ACC/AHA/HFSA ... Guideline for the Management ... Task Force on Clinical ... Practice Guidelines and ... #HeartFailure #Management
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... summarizes the A1C ... #pharmacology #pharmacotherapy ... #table #comparison ... #management #medications
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
recommended by the ACC ... #sCHF #HeartFailure ... #HFrEF #Pharmacology ... #Management #Treatment ... #StageC #Cardiology
Single Syringe Adenosine - Instructions
1) Dilute 6-12 mg of adenosine in a syringe for a total
patient's arm Clinical ... to place IV in AC ... #Instructions #pharmacology ... #SVT #cardiology ... #management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
differential #algorithm #management ... #cardiology #treatment ... #table #foamed ... #heartfailure #chf ... #pharmacology
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
Fraction (HFrEF) Clinical ... endomyocardial biopsy Pharmacology ... heartfailure #diagnosis #management ... #cardiology #pharmacology ... #sCHF
GLP-1 Medications: Ozempic vs. Trulicib (semaglutide vs. dulaglutide) 

From my experience, Ozempic and Trulicity are the
GLP-1 Medications ... However, clinical ... additional -0.3% A1c ... #dulaglutide #Pharmacology ... #Diabetes #Comparison
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... disease b) CHF ... Change in clinical ... one post op Cardiology ... surgical management